Category: Multiple Sclerosis (MS)
Global Multiple Sclerosis (MS)
-
Neurological Biomarkers Market by Type (Genomic, Imaging, Metabolomic), Application (Alzheimer’s Disease, Autism Spectrum Disorders, Multiple Sclerosis), End-user - Global Forecast 2024-2030
... expected to reach USD 10.24 billion in 2024, at a CAGR 14.05% to reach USD 22.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurological Biomarkers Market. It ... Read More
-
Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Global Forecast 2024-2030
... to reach USD 93.56 billion in 2024, at a CAGR 10.73% to reach USD 173.25 billion by 2030. Global Specialty Generics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Specialty ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.42 billion in 2024, at a CAGR 7.62% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Multiple Sclerosis Market by Treatment Modality (Injectable Agents, Oral Agents), Application (Hospital, Research) - Global Forecast 2024-2030
... 18.05 billion in 2024, at a CAGR 8.25% to reach USD 29.09 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Multiple Sclerosis Market. It offers a comprehensive assessment ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
... reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... global neurological biomarkers market size is expected to reach USD 18.75 billion by 2030, expanding at a CAGR of 12.89% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increased ... Read More
-
Interferons Market Forecasts to 2030 – Global Analysis By Product (Interferon Gamma, Interferon Beta, Interferon Alpha and Other Products), Application (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Hepatitis B, Melanoma, Leukemia, AIDS, Kaposi Sarcoma, Renal Cell Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography
... Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography According to Stratistics MRC, the Global Interferons Market is ... Read More
-
Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 33.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2022-2028. Multiple sclerosis (MS) refers to a chronic and inflammatory immune-mediated condition that can cause demyelination, axonal transection and neurodegeneration of ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030
... 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, ... Read More
-
Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030
... by 2030. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. Autoimmune diseases can be divided into ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
Specialty Generics Market Forecasts to 2028 – Global Analysis By Type (Oral Drugs, Injectables, Topical, Parenteral and Other Types), By Application (Hepatitis C, Multiple Sclerosis, Inflammatory Conditions, Oncology, Cardiovascular, Infectious Diseases, Autoimmune Diseases and Other Applications), By End User and By Geography
... Applications), By End User and By Geography According to Stratistics MRC, the Global Specialty Generics Market is accounted for $69.9 billion in 2022 and is expected to reach $176.6 billion by 2028 growing at a ... Read More
-
Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from ... Read More
-
Autoinjectors Market - By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular), By Therapy, (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Oncology, Asthma, Migraine, Hormone Therapy), By End-use (Hospital & Clinics, Homecare Settings) & Global Forecast, 2023 - 2032
... Forecast, 2023 - 2032 Global Autoinjectors Market is slated to grow exponentially by 2032, owing to the rising demand for targeted therapies, in light of the growing prevalence of chronic diseases. In addition, introduction to ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market Growth 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Multiple Sclerosis (MS) Drugs sales for 2023 through 2029. With Multiple Sclerosis (MS) Drugs sales broken down by region, market sector and sub-sector, ... Read More
-
Neurodegenerative Drugs Market By Drug Class (Dopamine agonist , Decarboxylase inhibitors , Cholinesterase Inhibitors , Immunomodulators, Others ), By Indication (Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis , Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031 The neurodegenerative drugs market valued for $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, exhibiting a CAGR of ... Read More
-
Global Multiple Sclerosis Drugs Market Size study & Forecast, by Drug Class (Immunomodulators, Immunosuppressants, Interferons) by Route of Administration (Oral, Injection), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... Multiple Sclerosis Drugs Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Multiple sclerosis is an ... Read More
-
Global Electronic Drug Delivery Systems Market Size study & Forecast, by Type (Wearable Infusion Pumps, Autoinjectors, Injection Pens and Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD and Other Indications) and Regional Analysis, 2022-2029
... Analysis, 2022-2029 Global Electronic Drug Delivery Systems Market is valued approximately USD 9.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. ... Read More
-
Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2023-2029
... disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2023-2029
... the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling. LPI (LP Information)' newest research report, the “Stem Cell Therapy for ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
Research Assistance
